The Novel Coronavirus 2019 epidemic and kidneys

Kidney International

Volumn 97, Issue 5, 2020, Pages 824-828

  Naicker, Saraladevi ^a   Yang, Chih Wei ^b   Hwang, Shang Jyh ^c   Liu, Bi Cheng ^d   Chen, Jiang Hua ^e   Jha, Vivekanand ^f,g  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^e ZHEJIANG UNIVERSITY   (China)

^f GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^g MANIPAL UNIVERSITY   (India)

Author keywords

acute kidney injury; hemodialysis

Indexed keywords

ALPHA INTERFERON; CHLOROQUINE; CORTICOSTEROID; LOPINAVIR PLUS RITONAVIR; REMDESIVIR; TOCILIZUMAB;

ACUTE KIDNEY FAILURE; ALBUMINURIA; ANTIVIRAL THERAPY; BED REST; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; EDITORIAL; EXTRACORPOREAL OXYGENATION; FLUID THERAPY; FLUORESCENT POLYMERASE CHAIN REACTION; GENE SEQUENCE; HEMATOLOGY; HEMATURIA; HEMODIALYSIS; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; KIDNEY DISEASE; MEDICAL HISTORY; NUCLEIC ACID ANALYSIS; NUTRITIONAL SUPPORT; OXYGENATION; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; QUARANTINE; SAFETY PROCEDURE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS EXAMINATION; BETACORONAVIRUS; HOST PATHOGEN INTERACTION; KIDNEY; PANDEMIC; PATHOGENICITY; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; VIROLOGY; VIRUS PNEUMONIA;

ACUTE KIDNEY INJURY; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; KIDNEY; KIDNEY DISEASES; PANDEMICS; PNEUMONIA, VIRAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 85081968148     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2020.03.001     Document Type: Editorial

References (32)

1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. https://doi.org/10.1001/jama.2020.1585. Accessed March 2, 2020.
2. World Health Organization. Coronavirus disease (COVID-2019) situation reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. (Accessed 16 March 2020)
3. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. (Accessed 2 March 2020)
4. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available at: https://www.who.int/csr/sars/country/table2004_04_21/en/. (Accessed 27 January 2020)
5. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). November 2019. Available at: http://www.who.int/emergencies/mers-cov/en/. (Accessed 27 February 2020)
6. Huang, C., Wang, Y., Li, X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395 (2020), 497–506.
7. Center for Disease Control and Prevention. Frequently asked questions and answers: Coronavirus Disease-2019 (COVID-19) and children. Available at: https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/children-faq.html. (Accessed 2 March 2020)
8. Ling, L., Taisheng, L., The National Health Commission of PRC Guideline for diagnosis and treatment of novel coronavirus disease (version 6). Natl Med J China, 100, 2020, E001.
9. World Health Organization. Specimen referral for 2019nCoV - operational details of referral laboratories. Available at: https://www.who.int/docs/default-source/coronaviruse/who-appointed-2019-ncov-referral-laboratories-7-february-2020.pdf?sfvrsn=c3fa3ec3_4. (Accessed 2 March 2020)
10. Normile, D., Singapore claims first use of antibody test to track coronavirus infections. Available at: https://www.sciencemag.org/news/2020/02/singapore-claims-first-use-antibody-test-track-coronavirus-infections. (Accessed 2 March 2020)
11. Chen, N., Zhou, M., Dong, X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513.
12. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2002032. Accessed March 2, 2020.
13. Cheng Y, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients [e-pub ahead of print]. medRxiv 2020.02.18.20023242. https://doi.org/10.1101/2020.02.18.20023242. Accessed March 2, 2020.
14. Li, Z., Wu, M., Guo, J., et al. Caution on kidney dysfunctions of 2019-nCoV patients. medRxiv 2020.02.08.20021212. (Accessed 2 March 2020)
15. Li, W., Moore, M.J., Vasilieva, N., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003), 450–454.
16. Raj, V.S., Mou, H., Smits, S.L., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495 (2013), 251–254.
17. Peiri, J.S.M., Chu, C.M., Cheng, V.C.C., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 (2003), 1767–1772.
18. Ding, Y., He, L., Zhang, Q., et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203 (2004), 622–630.
19. The team of Zhong Nanshan responded that the isolation of SARS-CoV-2 from urine remind us to pay more attention to the cleaning of individuals and families. Guangzhou Daily, Published February 22, 2020.
20. Expert Team of Chinese Society of Nephrology. Expert consensus on diagnosis and treatment of 2019 novel coronavirus (2019 - nCoV) infection with acute kidney injury. Chin J Nephrol, 3, 2020 https://doi.org/10.3760/cma.j.cn441217-20200222-00035.
21. Gao, J., Tian, Z., Yang, X., Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 14 (2020), 72–73.
22. Chu, K.H., Tsang, W.K., Tang, C.S., et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int 67 (2005), 698–705.
23. Arabi, Y.M., Arifi, A.A., Balkhy, H.H., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160 (2014), 389–397.
24. Ghani, R.A., Zainudin, S., Ctkong, N., et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton) 11 (2006), 386–393.
25. Chen, R.C., Tang, X.P., Tan, S.Y., et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest 129 (2006), 1441–1452.
26. Arabi, Y.M., Mandourah, Y., Al-Hameed, F., et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 197 (2018), 757–767.
27. Stockman, L.J., Bellamy, R., Garner, P., SARS: systematic review of treatment effects. PLoS Med, 3, 2006, e343.
28. Russell, C.D., Millar, J.E., Baillie, J.K., Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395 (2020), 473–475.
29. Park, B.K., Maharjan, S., Lee, S.I., et al. Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex. BMB Rep 52 (2019), 397–402.
30. Ma, Y., Diao, B., Lv, X., et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: report from one HD center in Wuhan, China. Available at: https://www.medrxiv.org/content/10.1101/2020.02.24.20027201v2. (Accessed 2 March 2020)
31. Expert Team of Chinese Medical Association Nephrology Branch. Recommendations for prevention and control of novel coronavirus infection in blood purification center (room) from Chinese Medical Association Nephrology Branch. Chin J Nephrol 36 (2020), 82–84.
32. Hwang, S.-J., Guideline for dialysis facilities during COVID-19 outbreak. Taiwan Society of Nephrology. Available at: https://tinyurl.com/yx3zc5up. (Accessed 16 March 2020)